Xiaozhong Qian
- Molecular Biology top 5%
- Oncology top 5%
- Physiology top 10%
- Cellular and Molecular Neuroscience top 10%
- Immunology
- Co-authors
- David D. GintyMichael JeffersHenri S. LichensteinMaxwell SehestedYuan ZhangLaura S. CollinsWilliam J. LaRochelleJames W.A. Ritchie
- Topics
- Histone Deacetylase Inhibitors Research (9 papers)Protein Degradation and Inhibitors (8 papers)Lung Cancer Research Studies (6 papers)
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Xiaozhong Qian
36 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Molecular Biology 1.3k
- Oncology 627
- Physiology 339
- Cellular and Molecular Neuroscience 260
- Immunology 211
Countries citing papers authored by Xiaozhong Qian
This map shows the geographic impact of Xiaozhong Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhong Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhong Qian more than expected).
Fields of papers citing papers by Xiaozhong Qian
This network shows the impact of papers produced by Xiaozhong Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhong Qian. The network helps show where Xiaozhong Qian may publish in the future.
Co-authorship network of co-authors of Xiaozhong Qian
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhong Qian. A scholar is included among the top collaborators of Xiaozhong Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhong Qian. Xiaozhong Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 23 | |
| 4 | 9 | |
| 5 | 7 | |
| 6 | 76 | |
| 7 | 23 | |
| 8 | 18 | |
| 9 | 7 | |
| 10 | 166 | |
| 11 | 36 | |
| 12 | 1 | |
| 13 | 10 | |
| 14 | 35 | |
| 15 | 47 | |
| 16 | 79 | |
| 17 | 117 | |
| 18 | Activity of the HDAC inhibitor, PXD101, used as monotherapy and combination therapy in preclinical NSCLC studies | 1 |
| 19 | 195 | |
| 20 | 316 |
About Xiaozhong Qian
Xiaozhong Qian is a scholar working on Oncology, Gastroenterology and Hematology, having authored 37 papers that have together received 2.0k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (9 papers), Protein Degradation and Inhibitors (8 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Oncology (627 citations), Molecular Biology (1.3k citations) and Cellular and Molecular Neuroscience (260 citations). Xiaozhong Qian has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include David D. Ginty, Michael Jeffers, Henri S. Lichenstein, Maxwell Sehested, Yuan Zhang, Laura S. Collins, William J. LaRochelle, James W.A. Ritchie, Ferenc Boldog and Sampath Kumar. Their work appears in journals such as Neuron, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.